# FSS #36F79727D006E

Interim Federal Supply Schedule Agreement with Replimune, Inc. for Hematology Products

**Buyer:** Department of Veterans Affairs

**Award Amount:** $25,000.00
**Ceiling:** $25,000.00

**Awarded:** November 01, 2026
**Period of Performance:** Nov 01, 2026 - Apr 30, 2027

**Identifier:** 36F79727D006E
**NAICS:** 325412

This award represents an interim agreement under a federal supply schedule contract, specifically Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Replimune, Inc., a biopharmaceutical company specializing in innovative therapies, reflecting their capability to supply specialized medical products. The procurement focuses on providing hematology and related pharmaceutical products, supporting the agency's healthcare and medical needs. This federal supply schedule contract signifies a streamlined procurement mechanism, allowing for efficient access to essential pharmaceuticals, which is crucial for timely and ongoing healthcare services. The scope includes supplying hematology-related products over a defined short-term period, with options for extension. The contract was awarded through the appropriate federal supply schedule vehicle, facilitating competitive and compliant sourcing; however, specific bidding details are not available. The performance period covers a multi-month timeframe within the next year, allowing for early delivery and potential further procurement under this schedule.

### Description

INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS

[View original record](https://www.usaspending.gov/award/CONT_IDV_36F79727D006E_3600)